Celldex Therapeutics shares owned by Citadel Advisors
Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by Citadel Advisors
from 13F filings
Historical chart of Citadel Advisors investment in Celldex Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Celldex Therapeutics held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Celldex Therapeutics by Citadel Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $9.5M | 240k | 39.66 |
| 2023-09-30 | $2.9M | 104k | 27.52 |
| 2023-06-30 | $4.6M | 137k | 33.93 |
| 2023-03-31 | $49M | 1.4M | 35.98 |
| 2022-12-31 | $38M | 853k | 44.57 |
| 2022-06-30 | $47M | 1.7M | 26.96 |
| 2022-03-31 | $47M | 1.4M | 34.06 |
| 2021-12-31 | $49M | 1.3M | 38.64 |
| 2021-09-30 | $58M | 1.1M | 53.99 |
| 2021-06-30 | $22M | 654k | 33.42 |
| 2021-03-31 | $25M | 1.2M | 20.60 |
| 2020-12-31 | $29M | 1.7M | 17.51 |
| 2020-09-30 | $4.0M | 271k | 14.88 |
| 2020-06-30 | $2.6M | 199k | 13.01 |
| 2020-03-31 | $67k | 40k | 1.67 |
| 2019-12-31 | $107k | 48k | 2.22 |
| 2019-09-30 | $27k | 13k | 2.14 |
| 2019-06-30 | $36k | 13k | 2.71 |
| 2019-03-31 | $94k | 19k | 4.92 |